首页> 美国卫生研究院文献>Clinical Translational Immunology >Targeting dendritic cells: a promising strategy to improve vaccine effectiveness
【2h】

Targeting dendritic cells: a promising strategy to improve vaccine effectiveness

机译:靶向树突状细胞:提高疫苗效力的有前途的策略

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Dendritic cell (DC) targeting is a novel strategy to enhance vaccination efficacy. This approach is based on the in situ delivery of antigen via antibodies that are specific for endocytic receptors expressed at the surface of DCs. Here we review the complexity of the DC subsets and the antigen presentation pathways that need to be considered in the settings of DC targeting. We also summarize current knowledge about antigen delivery to DCs via DEC-205, Clec9A and Clec12A, receptor targets that strongly enhance cellular and humoral immune responses. Finally, we discuss the intracellular trafficking criteria of the targeted receptors that may impact their effectiveness as DC targets.
机译:树突状细胞(DC)靶向是提高疫苗接种效力的新策略。该方法基于通过对DC表面表达的内吞受体特异的抗体原位递送抗原。在这里,我们回顾了DC子集的复杂性以及在DC靶向设置中需要考虑的抗原呈递途径。我们还总结了当前有关通过DEC-205,Clec9A和Clec12A抗原传递至DC的知识,这些受体可以极大地增强细胞和体液免疫反应。最后,我们讨论了靶向受体的细胞内运输标准,这可能会影响其作为DC靶的有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号